Transcript of above video:
We investigated the impact of switching from a conventional to a more sensitive cardiac troponin assay in several European hospitals and we were able to present and publish this data in European Heart Journal for more than 2,500 patients. And what we could see is that there was no increase in coronary angiography after switching to a more sensitive essay.
So physicians are often concerned about too many false positives, what they consider it to be. So they are afraid that too many patients will get unnecessary coronary angiography. But rates of coronary angiography and also PCIs remain completely stable during both phases. Of note and we were really surprised to see that, however, there was a substantial reduction of the need of subsequent cardiac stress testing of more than 30%. So obviously since high sensitivity opens a window around the 99th percentile, it gives more information for the clinicians that they can trust on safety of patient presenting with very low levels, so that they do not need, in all cases, subsequent cardiac stress testing. Furthermore, we could also see it was associated with a substantial reduction of duration in the ED, more than 80 minutes, which resulted in total – 20% cost reduction in outpatients.
